Antiplatelet drugs in the secondary prevention of myocardial infarction. One view of the present position.
D001241:Aspirin / Q000627:therapeutic use*; D001792:Blood Platelets / Q000187:drug effects*; D003327:Coronary Disease / Q000401:mortality; D004176:Dipyridamole / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000097:blood / Q000517:prevention & control*; D012008:Recurrence; D012306:Risk; D013442:Sulfinpyrazone / Q000627:therapeutic use*; D013927:Thrombosis / Q000517:prevention & control
D004176:Dipyridamole; D001241:Aspirin; D013442:Sulfinpyrazone